鲁比斯科林-6类型的神经保护和抗炎作用与位于2位的类替代品
Renata Perlikowska1, Joana Silva2, Celso Alves3
1Department of Biomolecular Chemistry, Faculty of Medicine, Medical University, Mazowiecka 6/8, 92-215, Lodz, Poland. renata.perlikowska@umed.lodz.pl.
鲁比斯科林-6类似物通过减少氧化应激和炎症,对帕金森病模型表现出神经保护作用. 这些激活AKT/mTOR通路,为新疗法和功能性食品提供了潜力.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 像鲁比斯科林这样的自然存在的体表现出中枢神经系统的活动.
- 鲁比斯科林因其强度而显示出作为口服药物候选物的潜力.
研究的目的:
- 研究鲁比斯科林-6 (R-6) 类型的神经保护和抗炎作用.
- 为了评估R-6类似物在6-氧多巴胺 (6-OHDA) 诱导的帕金森病模型和脂多糖 (LPS) 刺激的巨细胞中.
主要方法:
- 评估了反应性氧物种 (ROS),线粒体膜潜力 (MMP),卡斯帕-3活性,脂质过氧化和氧化 (NO) 生产.
- 研究了氨酸-氨酸激酶 (AKT) 和哺乳动物目标拉巴胺素 (mTOR) 途径的激活.
- 使用了人类神经母细胞瘤SH-SY5Y细胞和RAW 264.7巨细胞.
主要成果:
- 相似的3,5,和7通过减少ROS,线粒体功能障碍和Caspase-3活性显著预防神经元死亡.
- 5和7增强了酸化-AKT (p-AKT) 和酸化-mTOR (p-mTOR) 的蛋白质表达.
- 选择的类似物通过抑制巨细胞中ROS和NO的产生来减少LPS介导的炎症.
结论:
- 在体外帕金森病模型中,R-6类似物表现出神经保护作用,可能是通过抗氧化机制.
- 强大的R-6类似物通过激活PI3-K/AKT/mTOR通路来抑制6-OHDA损伤.
- 这些发现支持R-6类似物作为新疗法或功能性食物用于神经保护的发展.
更多相关视频
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
10:31Residue-Specific Exchange of Proline by Proline Analogs in Fluorescent Proteins: How "Molecular Surgery" of the Backbone Affects Folding and Stability
Published on: February 3, 2022
相关概念视频
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Antiepileptic Drugs: Glutamate Antagonists
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
